Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mekalanos

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
Infection and Immunity|May 24, 2005
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccinesBenedikt A Aulinger, Michael H Roehrl, John J Mekalanos, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2022
Intratumoral injection of schwannoma with attenuated <i>Salmonella typhimurium</i> induces antitumor immunity and controls tumor growthSherif G Ahmed, Giulia Oliva, Manlin Shao, et al.
Microbial Pathogenesis|April 1, 1988
Morphological studies on fimbriae expressed by Vibrio cholerae 01R H Hall, P A Vial, J B Kaper, et al.
Infection and Immunity|December 1, 1993
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitroF M Apter, W I Lencer, R A Finkelstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2003
CTXphi-independent production of the RS1 satellite phage by Vibrio choleraeShah M Faruque, M Kamruzzaman, Asadulghani, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic diseaseMichelle Dziejman, Emmy Balon, Dana Boyd, et al.
Infection and Immunity|October 18, 2000
Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cellsS F Mel, K J Fullner, S Wimer-Mackin, et al.
Infection and Immunity|March 1, 1991
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infectionL Winner, J Mack, R Weltzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2019
An onboard checking mechanism ensures effector delivery of the type VI secretion system in <i>Vibrio cholerae</i>Xiaoye Liang, Fatima Kamal, Tong-Tong Pei, et al.
Cell Host & Microbe|August 17, 2011
RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expressionAnjali Mandlik, Jonathan Livny, William P Robins, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
Infection and Immunity|May 24, 2005
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccinesBenedikt A Aulinger, Michael H Roehrl, John J Mekalanos, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2022
Intratumoral injection of schwannoma with attenuated <i>Salmonella typhimurium</i> induces antitumor immunity and controls tumor growthSherif G Ahmed, Giulia Oliva, Manlin Shao, et al.
Microbial Pathogenesis|April 1, 1988
Morphological studies on fimbriae expressed by Vibrio cholerae 01R H Hall, P A Vial, J B Kaper, et al.
Infection and Immunity|December 1, 1993
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitroF M Apter, W I Lencer, R A Finkelstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2003
CTXphi-independent production of the RS1 satellite phage by Vibrio choleraeShah M Faruque, M Kamruzzaman, Asadulghani, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2002
Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic diseaseMichelle Dziejman, Emmy Balon, Dana Boyd, et al.
Infection and Immunity|October 18, 2000
Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cellsS F Mel, K J Fullner, S Wimer-Mackin, et al.
Infection and Immunity|March 1, 1991
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infectionL Winner, J Mack, R Weltzin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2019
An onboard checking mechanism ensures effector delivery of the type VI secretion system in <i>Vibrio cholerae</i>Xiaoye Liang, Fatima Kamal, Tong-Tong Pei, et al.
Cell Host & Microbe|August 17, 2011
RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expressionAnjali Mandlik, Jonathan Livny, William P Robins, et al.
Pageof 29